☆ 4.6 Article

Serum Anti-Mullerian Hormone Levels Might Indicate Premenopausal Endometrial Lesions

DIAGNOSTICS (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Add to Collection

Review Obstetrics & Gynecology

Management of pre-, peri-, and post-menopausal abnormal uterine bleeding: When to perform endometrial sampling?

Efthymia Papakonstantinou et al.

Summary: Abnormal uterine bleeding (AUB) is a common symptom in women of all ages, with the International Federation of Gynecology and Obstetrics (FIGO) introducing the acronym PALM-COEIN to facilitate evaluation and differential diagnosis in premenopausal women. Endometrial evaluation is recommended for high-risk patients and low-risk patients with poor response to medical treatment, using modalities such as ultrasound or hysteroscopic imaging and tissue sampling.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2022)

Add to Collection

Article Medicine, General & Internal

Cancer statistics in China and United States, 2022: profiles, trends, and determinants

Changfa Xia et al.

Summary: The study compared the latest cancer profiles, trends, and determinants between China and the USA in 2022. China has a higher incidence of lung cancer, while the USA has more cases of breast cancer. Recent years have seen a significant decrease in lung and colorectal cancer rates in the USA, while liver cancer rates have slightly increased. In China, rates for stomach, liver, and esophageal cancer have decreased gradually, but colorectal cancer rates have increased for the whole population.

CHINESE MEDICAL JOURNAL (2022)

Add to Collection

Review Obstetrics & Gynecology

Accuracy of cytological examination of Tao brush endometrial sampling in diagnosing endometrial premalignancy and malignancy

Antonio Raffone et al.

Summary: A systematic review and meta-analysis showed that cytological examination from Tao brush endometrial sampling has a high diagnostic accuracy in diagnosing endometrial premalignancy and malignancy. It can be proposed as a screening and diagnostic tool, but further studies are needed to confirm these findings.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2022)

Add to Collection

Review Medicine, General & Internal

Endometrial cancer

Emma J. Crosbie et al.

Summary: Endometrial cancer is the most common gynaecological cancer in high income countries, with a global rise in incidence. Obesity is the major underlying cause, posing challenges for diagnosis and treatment. Early presentation with postmenopausal bleeding ensures cure, but advanced cases have poor prognosis. Minimally invasive surgical staging and targeted chemotherapeutic strategies are important advances.

LANCET (2022)

Add to Collection

Article Obstetrics & Gynecology

Identification and characterization of endometrial carcinoma with tumor markers HE4 and CA125 in serum and endometrial tissue samples

Tatiana Cuesta-Guardiola et al.

Summary: This study found a poor correlation between tissue HE4 and endometrial carcinoma, but serum HE4 was significant for the diagnosis of EC, while CA125 levels were not significant. These findings suggest that HE4 may be helpful in diagnosing EC.

JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Reproductive Biology

Abnormalities of early folliculogenesis and serum anti-Mullerian hormone in chinese patients with polycystic ovary syndrome

Juan Du et al.

Summary: Abnormalities of early folliculogenesis and higher AMH concentrations were found in PCOS patients. The study suggests that AMH may be used as a biomarker for diagnosing PCOS due to its close correlation with early-stage follicle disorders. This provides new insights into the mechanism of PCOS and directions for future research.

JOURNAL OF OVARIAN RESEARCH (2021)

Add to Collection

Review Medical Laboratory Technology

Endometrial cancer: A systematic review of HE4, REM and REM-B

Manon Degez et al.

Summary: HE4, alone or combined with CA125, shows potential for diagnosis, prognosis, and monitoring of recurrence in endometrial cancer. Further prospective studies are needed to confirm its clinical utility.

CLINICA CHIMICA ACTA (2021)

Add to Collection

Review Endocrinology & Metabolism

Anti-Mullerian Hormone in Female Reproduction

Nathalie di Clemente et al.

Summary: Anti-Mullerian hormone (AMH) plays a significant role in regulating folliculogenesis and serves as a reliable marker for ovarian reserve. It is also involved in the pathogenesis of conditions like polycystic ovary syndrome (PCOS) and primary ovarian failure.

ENDOCRINE REVIEWS (2021)

Add to Collection

Article Medicine, General & Internal

Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?

Aneta Cymbaluk-Ploska et al.

Summary: The study found that CA125 and HE4 can serve as prognostic factors in patients with endometrial cancer, affecting their disease-free survival (DFS) and overall survival (OS). Additionally, HE4 was found to be a sensitive tool for predicting the risk of recurrence and overall survival in these patients.

DIAGNOSTICS (2021)

Add to Collection

Article Oncology

Tao brush endometrial cytology is a sensitive diagnostic tool for cancer and hyperplasia among women presenting to clinic with abnormal uterine bleeding

Stephanie R. DeJong et al.

Summary: This study demonstrates that Tao brush endometrial cytology shows high sensitivity in detecting atypical hyperplasia and endometrial cancer in a high-risk population, comparable to biopsy histology. Revisiting the potential value of endometrial cytology in the contemporary era of endometrial diagnostic workup is warranted.

CANCER MEDICINE (2021)

Add to Collection

Review Oncology

HE4 as a Biomarker for Endometrial Cancer

Roya Behrouzi et al.

Summary: There are currently no blood biomarkers approved for routine clinical use in endometrial cancer. Serum human epididymis protein 4 (HE4) is significantly higher in patients with endometrial cancer compared to patients without endometrial cancer and is associated with a poorer prognosis. This makes HE4 an attractive candidate for clinical use in endometrial cancer.

CANCERS (2021)

Add to Collection

Article Obstetrics & Gynecology

Rate of premalignant and malignant endometrial lesion in low-risk premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy

Sangam Jha et al.

Summary: The incidence of EH/EC was lower in low-risk premenopausal women with AUB. However, premenopausal women with IMB aged >40 years, hypothyroidism, BMI >25 kg/m(2), and thickened endometrium (ET >13 mm) are at high risk of EH/EC. Therefore, endometrial biopsy should be considered early in their management plan.

OBSTETRICS & GYNECOLOGY SCIENCE (2021)

Add to Collection

Article Oncology

Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: A prospective multicentre cohort study

Casper Reijnen et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Add to Collection

Review Multidisciplinary Sciences

Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis

Michelle T. Doherty et al.

PLOS ONE (2020)

Add to Collection

Article Genetics & Heredity

Bioinformatic screening for candidate biomarkers and their prognostic values in endometrial cancer

Yaowei Li et al.

BMC GENETICS (2020)

Add to Collection

Article Oncology

A Clinical Comparative Study of Two Different Endometrial Cell Samplers for Evaluation of Endometrial Lesions by Cytopathological Diagnosis

Shulan Lv et al.

CANCER MANAGEMENT AND RESEARCH (2020)

Add to Collection

Article Medicine, General & Internal

Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal Women

Jacopo Troisi et al.

JAMA NETWORK OPEN (2020)

Add to Collection

Review Medicine, General & Internal

Endometrial Cancer

Karen H. Lu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, Research & Experimental

Elevated CA-125 Level and ER-Negative as Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer: A Retrospective Cohort Study

Xiaoting Ling et al.

MEDICAL SCIENCE MONITOR (2020)

Add to Collection

Review Oncology

Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer

Kelechi Njoku et al.

FRONTIERS IN ONCOLOGY (2020)

Add to Collection

Article Oncology

Preoperative markers for the prediction of high-risk features in endometrial cancer

Pinyada Panyavaranant et al.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Oncology

A New Risk Index Combining d-Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial Cancer From Patients With Abnormal Vaginal Bleeding or Discharge

Lili Ge et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)

Add to Collection

Review Obstetrics & Gynecology

AMH and Its Clinical Implications

Laxmi Shrikhande et al.

JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA (2020)

Add to Collection

Review Oncology

New perspectives on screening and early detection of endometrial cancer

Laura Costas et al.

INTERNATIONAL JOURNAL OF CANCER (2019)

Add to Collection

Article Endocrinology & Metabolism

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Helena J. Teede et al.

CLINICAL ENDOCRINOLOGY (2018)

Add to Collection

Article

HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients

Karin Abbink et al.

TUMOR BIOLOGY (2018)

Add to Collection

Review Obstetrics & Gynecology

Premenopausal abnormal uterine bleeding and risk of endometrial cancer

Me Pennant et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2017)

Add to Collection

Review Obstetrics & Gynecology

Criteria, prevalence, and phenotypes of polycystic ovary syndrome

Daria Lizneva et al.

FERTILITY AND STERILITY (2016)

Add to Collection

Review Medicine, General & Internal

Endometrial cancer

Philippe Morice et al.

LANCET (2016)

Add to Collection

Review Chemistry, Multidisciplinary

Cancer biomarker detection: recent achievements and challenges

Li Wu et al.

CHEMICAL SOCIETY REVIEWS (2015)

Add to Collection

Article Obstetrics & Gynecology

Two new automated, compared with two enzyme-linked immunosorbent, antimullerian hormone assays

Scott M. Nelson et al.

FERTILITY AND STERILITY (2015)

Add to Collection

Article Obstetrics & Gynecology

Performance of the two new fully automated anti-Mullerian hormone immunoassays compared with the clinical standard assay

Josef van Helden et al.

HUMAN REPRODUCTION (2015)

Add to Collection

Article Obstetrics & Gynecology

Prediction of endometrial carcinogenesis probability while diagnosed as atypical endometrial hyperplasia: a new risk model based on age, CA199 and CA125 assay

Lina Zhou et al.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2014)

Add to Collection

Article Obstetrics & Gynecology

Prediction of Regression and Relapse of Endometrial Hyperplasia With Conservative Therapy

Ioannis D. Gallos et al.

OBSTETRICS AND GYNECOLOGY (2013)

Add to Collection

Review Oncology

Cancer biomarkers

N. Lynn Henry et al.

MOLECULAR ONCOLOGY (2012)

Add to Collection

Article Obstetrics & Gynecology

Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone

C. Villarroel et al.

HUMAN REPRODUCTION (2011)

Add to Collection

Article Obstetrics & Gynecology

ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria

A. P. Ferraretti et al.

HUMAN REPRODUCTION (2011)

Add to Collection

Article Oncology

Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort

Ian Jacobs et al.

LANCET ONCOLOGY (2011)

Add to Collection

Article Oncology

Receiver Operating Characteristic Curve in Diagnostic Test Assessment

Jayawant N. Mandrekar

JOURNAL OF THORACIC ONCOLOGY (2010)

Add to Collection

Article Oncology

Body Mass Index and Risk of Ovarian Cancer

Michael F. Leitzmann et al.

CANCER (2009)

Add to Collection

Article Obstetrics & Gynecology

Factors affecting adequacy of Pipelle and Tao Brush endometrial sampling

A. R. W. Williams et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2008)

Add to Collection

Article Oncology

The role of L1-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women

A. Ben-Arie et al.

EJSO (2008)

Add to Collection

Article Developmental Biology

Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment

C Weenen et al.

MOLECULAR HUMAN REPRODUCTION (2004)

Add to Collection

Article Obstetrics & Gynecology

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)

BCJM Fauser et al.

HUMAN REPRODUCTION (2004)

Add to Collection

Article Endocrinology & Metabolism

Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest

P Pigny et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.